Pharmacokinetics, Pharmacodynamics, and Safety of Evocalcet (KHK7580), a Novel Calcimimetic Agent: An Open-Label, Single- and Multiple-Dose, Phase I Trial in Healthy Chinese Subjects.

Purpose: This study explored the pharmacokinetics (PK), pharmacodynamics (PD), and safety of evocalcet (KHK7580), a new calcimimetic agent, in healthy Chinese subjects following single and multiple doses.

Methods: This was a single-center, open-label phase I trial conducted in China. The study started from the single-dose cohorts (1, 3, 6, 12 mg evocalcet, step-by-step administration) and proceeded to the multiple-dose cohort (6 mg evocalcet once daily for eight days).

Comparison of the Oral Calcimimetics Evocalcet and Cinacalcet in East Asian Patients on Hemodialysis with Secondary Hyperparathyroidism.

Introduction: Evocalcet is an oral calcimimetic agent with proven efficacy and safety in treating secondary hyperparathyroidism (SHPT) in Japanese patients on dialysis.

Methods: This randomized, double-blind, intrapatient dose-adjustment, parallel-group, international multicenter study compared the efficacy and safety of evocalcet versus cinacalcet for 52 weeks in East Asian hemodialysis patients with SHPT.

Results: In total, 203 and 200 patients were randomized to receive evocalcet or cinacalcet, respectively (overall, 70.

Deep learning driven de novo drug design based on gastric proton pump structures.

Existing drugs often suffer in their effectiveness due to detrimental side effects, low binding affinity or pharmacokinetic problems. This may be overcome by the development of distinct compounds. Here, we exploit the rich structural basis of drug-bound gastric proton pump to develop compounds with strong inhibitory potency, employing a combinatorial approach utilizing deep generative models for de novo drug design with organic synthesis and cryo-EM structural analysis.

First Report of the Physiological Race (XXIV) of (Coffee Leaf Rust) in Hawaii.

Hawaii's coffee industry, produced commercially on six islands by over 1,470 growers on ~10,000 acres, is conservatively valued at $100M per year (USDA NASS 2023). Until late October 2020, Hawaii was the only major coffee producing region of the world that was free of Coffee Leaf Rust (CLR). Growers are currently facing their most formidable production challenge with the arrival of Berk.

Diet quality and depressive symptoms among workers.

Background & Aim: It is not clear whether diet quality influences mental health. We prospectively investigated the association of adherence to the Japanese dietary guidelines with depressive symptoms in a Japanese working population.

Methods: Participants were 909 workers (aged 19-68 years) without depressive symptoms at baseline who completed both baseline and 3-year follow-up surveys.